Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit

2026年6月15日 · メモを表示

Podcasts

このエピソードについて

Featuring perspectives from Dr Manali Kamdar, Dr Krish Patel and Dr Gilles Salles, including the following topics:

Introduction (0:00)
Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles (7:05)
Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel (26:21)
Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar (43:12)
CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles (1:08:33)
Other Approved and Emerging Novel Therapies for FL — Dr Patel (1:24:44)
Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar (1:41:34)

CME information and select publications

医学

教育

健康／フィットネス

医学

科学

英語

アメリカ合衆国

APIを使用して、JSONでこのエピソードを取得します

エピソード内

dr gilles salle

# krish patel

dr manali kamdar

これらのタグを編集

メモを表示 🔗

00:00:00Introduction

00:07:05Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles

00:26:21Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel

00:43:12Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar

01:08:33CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles

01:24:44Other Approved and Emerging Novel Therapies for FL — Dr Patel

01:41:34Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar

文字起こし 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

過去のエピソードを検索

Oncology Today with Dr Neil Loveの以前のエピソードを検索します。

この検索バーをあなたのウェブサイトに埋め込む

このポッドキャストの他のエピソード

Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

2026年10月17日

Featuring a slide presentation from Dr Julia Rotow, including the following topics: Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00) Key findings from the Phase III HA…